Verastem Oncology
VSTM
$9.98
Share price
0.00%
Change (1 day)
2,168.18%
Change (1 year)
Categories
Verastem Oncology (VSTM) - Net assets
Net assets on the balance sheet as of December 2023 : $57.37 M
According to Verastem Oncology
's latest financial reports the company has $57.37 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Verastem Oncology - Net assets on balance sheet (from 2011 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $47.39 M | -45.88% |
| 2021-12-31 | $87.55 M | -24.04% |
| 2020-12-31 | $0.11 B | 1506.83% |
| 2019-12-31 | $7.17 M | -94.23% |
| 2018-12-31 | $0.12 B | 115.48% |
| 2017-12-31 | $57.68 M | -20.21% |
| 2016-12-31 | $72.29 M | -29.45% |
| 2015-12-31 | $0.10 B | 15.44% |
| 2014-12-31 | $88.76 M | -24.42% |
| 2013-12-31 | $0.11 B | 29.82% |
| 2012-12-31 | $90.46 M | 63.37% |
| 2011-12-31 | $55.37 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 155,524.50% | 🇺🇸 USA |
 LabCorp LH | $7.89 B | 13,652.75% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.28 B | 28,289.17% | 🇬🇧 UK |
 Curis CRIS | $19.67 M | -65.72% | 🇺🇸 USA |